Filing Details

Accession Number:
0001235802-23-000105
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-10-04 16:11:34
Reporting Period:
2023-08-30
Accepted Time:
2023-10-04 16:11:34
Original Submission Date:
2023-08-31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1253176 Vapotherm Inc VAPO Surgical & Medical Instruments & Apparatus (3841) 462259298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752635 L. Anthony Arnerich 100 Domain Drive
Exeter NH 03833
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-30 5,000 $2.90 11,759 No 4 P Direct
Common Stock Acquisiton 2023-08-31 12,750 $3.10 24,509 No 4 P Direct
Common Stock Acquisiton 2023-08-31 20,000 $3.17 47,921 No 4 P Indirect By Anthony L. Arnerich Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Indirect By Anthony L. Arnerich Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,112 Indirect By Christine A. Arnerich Trust
Common Stock 149,201 Indirect By 3x5 Partners, LLC
Footnotes
  1. The purpose of this Form 4 amendment (this "Form 4/A") is to adjust the amount of securities beneficially owned following the reported transactions by the reporting person to reflect a 1-for-8 reverse split of the common stock of Vapotherm, Inc. effective August 18, 2023. In addition, proportionate adjustments have been made to the reporting person's outstanding equity awards, including the number of restricted stock units as reflected on this Form 4/A and described in footnote (3) to this Form 4/A, to reflect the 1-for-8 reverse stock split.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.8479 to $3.15, inclusive. The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4/A.
  3. Includes 18,375 shares held by the Reporting Person's IRA and 3,281 shares that will be issued over time upon the vesting and settlement of restricted stock unit awards.
  4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.9991 to $3.25, inclusive. The reporting person undertakes to provide to Vapotherm, Inc., any security holder of Vapotherm, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4/A.
  5. Consists of (i) 985 shares held by Arnerich 3x5 Special Opportunity Managers, L.P., of which 3x5 Partners, LLC is the general manager, (ii) 98,844 shares directly held by Vapotherm Investors, LLC, and (iii) 49,372 shares directly held by 3x5 Special Opportunity Fund, L.P.
  6. The Reporting Person is a managing member of 3x5 Partners, LLC. 3x5 Partners, LLC is the managing member of Vapotherm Investors, LLC and a member of 3x5 Special Opportunity Partners, LLC, which is the general partner of 3x5 Special Opportunity Fund, L.P., and by virtue of these relationships 3x5 Partners, LLC may be deemed to indirectly beneficially own the shares directly held by Vapotherm Investors, LLC and 3x5 Special Opportunity Fund, L.P. As a managing member of 3x5 Partners, LLC the Reporting Person shares voting and dispositive power over such securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, of such securities except to the extent of his pecuniary interest therein.